Hyrra Features the Latest and Most Talked-About Topstories News and Headlines from Around the World.
⎯ 《 Hyrra • Com 》

List of All Articles with Tag 'novob dc'

Suicide Risk From Weight-Loss Drugs Prompts More Questions
Suicide Risk From Weight-Loss Drugs Prompts More Questions
The European Union’s drugs regulator has asked pharma companies including Novo Nordisk A/S and Eli Lilly & Co.
2023-12-02 06:00
Altimmune Jumps 66% After Positive Results for Its Obesity Drug
Altimmune Jumps 66% After Positive Results for Its Obesity Drug
Altimmune Inc. jumped as much as 66% in late trading after the biotech company reported results from a
2023-12-01 07:24
Long-Time Novo Bull Slashes Stake Citing Weight-Loss Drug Hype
Long-Time Novo Bull Slashes Stake Citing Weight-Loss Drug Hype
A top-performing European fund manager is calling time on “hype” around weight-loss drugs that has sent Novo Nordisk
2023-11-27 16:47
Ozempic Maker Novo Nordisk Invests $2.3 Billion in France Site
Ozempic Maker Novo Nordisk Invests $2.3 Billion in France Site
Novo Nordisk A/S plans to invest €2.1 billion ($2.3 billion) to expand production in France as it works
2023-11-24 02:00
New ETF Tracks Developers of Obesity Drugs Amid Ozempic Hype
New ETF Tracks Developers of Obesity Drugs Amid Ozempic Hype
A niche issuer is launching a biotechnology exchange-traded fund whose key holdings include firms benefiting from the hype
2023-11-21 20:50
Novo Nordisk Staff Get Free Wegovy As a Perk If They Need It
Novo Nordisk Staff Get Free Wegovy As a Perk If They Need It
If you’re a Novo Nordisk A/S employee with obesity, you will have access to a unique company perk:
2023-11-16 00:27
Germany Mulls Obesity Drug Export Ban as EU Confronts Shortage
Germany Mulls Obesity Drug Export Ban as EU Confronts Shortage
Germany is considering an export ban on Novo Nordisk A/S’s blockbuster weight-loss drugs as European countries try to
2023-11-15 18:55
Novo Shares Rise After Wegovy Demonstrates Heart Benefit in Trial
Novo Shares Rise After Wegovy Demonstrates Heart Benefit in Trial
Novo Nordisk A/S shares surged after a key study backed the use of Wegovy, its blockbuster weight-loss drug,
2023-11-13 17:19
Wegovy Study Bolsters Use In Patients With Obesity and Heart Disease
Wegovy Study Bolsters Use In Patients With Obesity and Heart Disease
Novo Nordisk A/S unveiled details from a closely watched study that support use of Wegovy, its blockbuster weight-loss
2023-11-11 21:59
Novo to Build $6 Billion Plant as Obesity Drug Demand Surges
Novo to Build $6 Billion Plant as Obesity Drug Demand Surges
Novo Nordisk A/S will invest more than 42 billion kroner ($6 billion) to expand its manufacturing facilities as
2023-11-10 21:29
Astra Enters Obesity Drug Race, Trumpets Price Potential
Astra Enters Obesity Drug Race, Trumpets Price Potential
AstraZeneca Plc clinched a deal to develop a drug from the pharma industry’s hottest class of medicines and
2023-11-09 21:57
New Ozempic Rival Is About to Make Your Weight Loss Drugs Cheaper
New Ozempic Rival Is About to Make Your Weight Loss Drugs Cheaper
An effective and massively popular weight-loss drug has made Novo Nordisk A/S billions of dollars and turned it
2023-11-09 07:20
«123»